Vienna, VA 22180
United States
http://https://www.cynaera.com/institute
CYNAERA Institute
SSRN RANKINGS
in Total Papers Downloads
ME/CFS, myalgic encephalomyelitis, chronic fatigue syndrome, Long COVID, prevalence correction, post-viral illness, neuroimmune, post-exertional malaise, RECOVER, IACC, remission dynamics, modeling study, infection associated chronic conditions
lupus, systemic lupus erythematosus, SLE, prevalence, underdiagnosis, diagnostic friction, post-COVID autoimmune, prevalence correction, health equity, autoimmune disease, race disparities, modeling study
environmental health, flare prediction, infection-associated chronic conditions, ME/CFS, Long COVID, POTS, MCAS, air quality, mold exposure, wildfire smoke, climate health, chronic illness, environmental modeling
post-exertional malaise, ME/CFS, threshold model, multi-domain load, intervention timing, trial design, environmental load, clinical trials
symptom cascade dynamics, temporal modeling, infection-associated chronic conditions, ME/CFS, POTS, Lyme disease, Long COVID, systems model, instability progression, chronic illness, post-infectious illness, autonomic dysfunction, immune-mediated conditions, longitudinal tracking
intimate partner violence, medical sabotage, chronic illness, infection-associated chronic conditions, Long COVID, ME/CFS, MCAS, dysautonomia, coercive control, health equity, invisible harm, prevalence correction, IACC, domestic violence, disability
Stage Zero, preclinical detection, autoimmune disease, Long COVID, ME/CFS, POTS, MCAS, pattern recognition, diagnostic delay, trajectory tracking, immune instability, autonomic dysfunction, seronegative autoimmunity, pre-diagnostic instability, infection-associated chronic conditions
disease prevalence, underdiagnosis, diagnostic capture, prevalence correction, health equity, epidemiology methods, chronic illness, autoimmune disease, diagnostic delay, structural bias, environmental health, lupus, me/cfs, long COVID
infection-associated chronic conditions, IACC, Long COVID, ME/CFS, dysautonomia, POTS, fibromyalgia, Lyme disease, chronic Lyme, PTLD, MCAS, mast cell activation, Sjogren's syndrome, small fiber neuropathy, hEDS, hypermobile Ehlers-Danlos, PANS, PANDAS, prevalence correction, underdiagnosis, US-CCUC, health equity, post-viral illness, chronic illness burden, epidemiology
ME/CFS, mold exposure, treatment response suppressor, clinical trial confounding, infection-associated chronic conditions, Long COVID, VitalGuard, CIRS, MARCoNS, alpha-MSH, mycotoxins, environmental health, housing condition, trial design, IACC research design, water-damaged buildings
infection-associated chronic conditions, Long COVID, ME/CFS, primary chronic trigger, multi-hit model, post-exertional malaise, environmental exposure, causal inference, prevalence modeling, IACC, ignition framework, burden modeling, chronic illness
Long COVID, post-acute sequelae, SARS-CoV-2, incidence modeling, US-CCUC™, public health, disease burden, Long COVID prevalence
infection-associated chronic conditions, IACC, ME/CFS, Long COVID, POTS, MCAS, dysautonomia, immune dysregulation, mitochondrial dysfunction, neuroinflammation, autonomic instability, post-exertional malaise, PEM, mast cell activation, clinical trial design, diagnostic delay, T cell exhaustion, terrain stabilization, cancer risk, EBV reactivation, mTOR pathway
tinnitus, Long COVID, post-COVID, phenotype classification, combination therapy, autonomic dysfunction, POTS, mast cell activation, MCAS, neuroinflammation, HEADPRESSURE-Mod, state-dependent, post-viral, infection-associated chronic conditions, IACC, sound sensitivity, cyproheptadine, glymphatic, neurovascular
